Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Antimicrobial Resistance Surveillance Market Expected To Become By 2029 Compared With Its 2025 Level?
The scope of the antimicrobial resistance surveillance market has seen significant expansion lately, projected to increase from a value of $6.77 billion in the year 2024 to $7.3 billion in 2025, reflecting a consistent compound annual growth rate of 7.9%; this robust upward trend during the past period stems from several key factors, including expanding antibiotic application within the agricultural sector, the frequent dispensing of antibiotics within medical settings, insufficient availability of diagnostic tools, inadequate maintenance of hygiene and infection management protocols, and the widespread interconnectedness fostered by international movement and commerce.
Forecasting robust expansion, the market tracking antimicrobial resistance surveillance is projected to achieve a valuation of $10.05 billion by 2029, demonstrating a steady compound annual growth rate of 8.3% throughout the upcoming years. This upward trajectory is fueled by several key factors, notably the heightened global consciousness regarding antimicrobial resistance, technological leaps in diagnostic methods, amplified governmental support and financial investment, the escalating incidence of infections acquired in healthcare settings, and ongoing efforts in discovering novel antibiotics alongside alternative treatments. Within this same timeframe, significant market trends are anticipated to encompass the utilization of artificial intelligence techniques for sophisticated data interpretation, the deployment of next-generation sequencing platforms, the establishment of monitoring systems capable of real-time feedback, the broader adoption of molecular diagnostic instruments, and the leveraging of big data combined with machine learning capabilities to develop predictive models.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21100&type=smp
Which Major Market Drivers Are Shaping The Future Of The Antimicrobial Resistance Surveillance Market?
Anticipated expansion in the antimicrobial resistance surveillance market is fueled by the growing incidence of contagious ailments in the future. These contagious ailments arise from detrimental microscopic organisms like bacteria, viruses, molds, or protozoa that possess the capacity to transmit between people either directly or indirectly. A surge in the frequency of these infectious sicknesses stems from elements such as shifts in weather patterns, the movement of populations into cities, and international transit, all of which facilitate the dispersal of disease-causing agents and increase human contact with novel microbes. Monitoring antimicrobial resistance is vital for tracing the propagation of resistant strains, thereby shaping successful treatment regimens and furnishing the necessary data for health authorities to implement measures against outbreaks of infectious disease. As an illustration, data released in February 2024 by the UK Health Security Agency, a governmental body in the United Kingdom, indicated that cases of tuberculosis (TB) within England saw a rise of 10.7% throughout 2023, reaching 4,850 reported instances, up from 4,380 the previous year, 2022. Consequently, the escalating rate of infectious disease occurrence is the impetus behind the market growth for antimicrobial resistance surveillance.
How Is The Antimicrobial Resistance Surveillance Market Segmented?
The antimicrobial resistance surveillancemarket covered in this report is segmented –
1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications
3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users
Subsegments:
1) By Diagnostic Kits: PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits
2) By Diagnostic Systems: Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems
3) By Surveillance Software: Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems
4) By Services: Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services
What Long-Term Trends Will Shape The Future Growth Of The Antimicrobial Resistance Surveillance Industry?
Leading firms within this sector are heavily invested in developing novel technological solutions, including advanced diagnostic instruments, with the aims of optimizing operational workflows, boosting overall performance, ensuring greater precision, lowering expenditures, and ultimately achieving superior results for both healthcare recipients and those utilizing the products. Speaking to the definition, a diagnostic tool encompasses any apparatus, application, hardware, or procedure employed to pinpoint, discover, or evaluate the existence of an ailment, sickness, operational failure, or specific problem. To offer a concrete illustration, in June of 2023, Sysmex Astrego AB, a Swedish entity specializing in the production and provision of diagnostic service offerings, unveiled the PA-100 AST Point-of-Care Testing System. This apparatus facilitates the swift and precise identification of microbial resistance right where care is administered, presenting a dramatic time saving when contrasted with conventional lab procedures that might necessitate days. Delivering findings within a mere half-hour empowers medical practitioners to enact prompt, data-driven choices regarding suitable infection therapies, thereby lessening the dependence on widespread antibiotic prescriptions and aiding the fight against the propagation of resistance to antimicrobials.
Who Are The Key Multinational Companies Dominating The Antimicrobial Resistance Surveillance Market?
Major companies operating in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Viatris Inc., Wolters Kluwer NV, Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen NV, Cepheid Inc., Shionogi & Co. Ltd., Venatorx Pharmaceuticals Inc., Accelerate Diagnostics Inc., Paratek Pharmaceuticals Inc., Liofilchem Srl, Lumed Inc., OpGen Inc.
Download The Full Report For Exclusive Market Findings:
Which Global Regions Are Influencing The Competitive Landscape Of The Antimicrobial Resistance Surveillance Market?
North America was the largest region in the antimicrobial resistance surveillance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance surveillance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Antimicrobial Resistance Surveillance Market Report:
https://www.thebusinessresearchcompany.com/customise?id=21100&type=smp
Browse Through More Reports Similar to the Global Antimicrobial Resistance Surveillance Market 2025, By The Business Research Company
Antimicrobial Susceptibility Testing Global Market Report 2025
Antimicrobial Medical Device Coatings Global Market Report 2025
Antimicrobial Textile Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/antimicrobial-textile-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model